Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H15N9O |
| Molecular Weight | 397.3928 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](NC1=NC=NC(N)=C1C#N)C2=NN3C=CC(C#N)=C3C(=O)N2C4=CC=CC=C4
InChI
InChIKey=QUMWKKVIZAIAHU-LBPRGKRZSA-N
InChI=1S/C20H15N9O/c1-12(26-18-15(10-22)17(23)24-11-25-18)19-27-28-8-7-13(9-21)16(28)20(30)29(19)14-5-3-2-4-6-14/h2-8,11-12H,1H3,(H3,23,24,25,26)/t12-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
548916
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
444614
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1MK0TQ597B
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
PRIMARY | |||
|
1403947-26-1
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
PRIMARY | |||
|
100000183853
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
PRIMARY | |||
|
EU/3/14/1335(POSITIVE)
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
PRIMARY | On 15 October 2014, orphan designation (EU/3/14/1335) was granted by the European Commission to Almirall S.A., Spain, for (S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile for the treatment of pemphigus. | ||
|
70675172
Created by
admin on Sat Dec 16 01:46:07 GMT 2023 , Edited by admin on Sat Dec 16 01:46:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
